Title : Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD).

Pub. Date : 2014 Apr 23

PMID : 24760190






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We hypothesized that the effect of aspirin may be antagonized by low 15-PGDH expression in the normal colon. Aspirin 15-hydroxyprostaglandin dehydrogenase Homo sapiens
2 Compared with nonuse, regular aspirin use was associated with lower risk of colorectal cancer that developed within a background of colonic mucosa with high 15-PGDH expression [multivariable HR, 0.49; 95% confidence interval (CI), 0.34 to 0.71], but not with low 15-PGDH expression (multivariable HR, 0.90; 95% CI, 0.63 to 1.27) (P for heterogeneity = 0.018). Aspirin 15-hydroxyprostaglandin dehydrogenase Homo sapiens
3 Compared with nonuse, regular aspirin use was associated with lower risk of colorectal cancer that developed within a background of colonic mucosa with high 15-PGDH expression [multivariable HR, 0.49; 95% confidence interval (CI), 0.34 to 0.71], but not with low 15-PGDH expression (multivariable HR, 0.90; 95% CI, 0.63 to 1.27) (P for heterogeneity = 0.018). Aspirin 15-hydroxyprostaglandin dehydrogenase Homo sapiens
4 Regular aspirin use was associated with lower incidence of colorectal cancers arising in association with high 15-PGDH expression, but not with low 15-PGDH expression in normal colon mucosa. Aspirin 15-hydroxyprostaglandin dehydrogenase Homo sapiens
5 This suggests that 15-PGDH expression level in normal colon mucosa may serve as a biomarker that may predict stronger benefit from aspirin chemoprevention. Aspirin 15-hydroxyprostaglandin dehydrogenase Homo sapiens